Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
Phase 2
Terminated
- Conditions
- Esophageal Diseases
- Registration Number
- NCT00208936
- Lead Sponsor
- Emory University
- Brief Summary
This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.
- Detailed Description
This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.
Exclusion Criteria
- Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Emory University Winship Cancer Institute
🇺🇸Atlanta, Georgia, United States